drugset / Trial / NCT04371627

Viaskin® Peanut (DBV712) Expanded Access Protocol

NCT04371627 ↗

Expanded access No longer available DBV Technologies

Summary

This is an open label expanded access program for male and female patients ≥ 4 years old.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Viaskin Peanut Protein / enzyme biologic — Other

Indications